Search
for
Sort by
Research 481–510 of 1000+
- Imaging prostate cancer (PCa) with [<sup>99m</sup> Tc(CO)<sub>3</sub> ]finasteride dithiocarbamate
- Associations between sun sensitive pigmentary genes and serum prostate specific antigen levels
- Intraethnic variation in steroid-5-alpha-reductase polymorphisms in prostate cancer patients: a potential factor implicated in 5-alpha-reductase inhibitor treatment
- Hormonal treatment for male-pattern hair loss: implications for cancer of the prostate?
- Causal associations between plasma proteins and prostate cancer: a Proteome-Wide Mendelian Randomization
- Hétérogénéité tumorale du cancer de la prostate et infection par le SARS-CoV2 : une relation complexe impliquant les vésicules extracellulaires et le récepteur des androgènes
- What do we know about phytotherapy of benign prostatic hyperplasia?
- Pharmacological Approaches in Managing Symptomatic Relief of Benign Prostatic Hyperplasia: A Comprehensive Review
- Finasteride, not tamsulosin, increases severity of erectile dysfunction and decreases testosterone levels in men with benign prostatic hyperplasia
- 5α- Reductase Inhibitors in Prostate Cancer: An Overview
- Pharmacological therapy of benign prostatic hyperplasia/lower urinary tract symptoms: an overview for the practising clinician
- Leydig Cell Hyperplasia and Adenomas in Mice Treated with Finasteride, a 5α-Reductase Inhibitor: A Possible Mechanism
- Analysis of Data From Breast Diseases Treated With 5-Alpha Reductase Inhibitors for Benign Prostatic Hyperplasia
- Five-alpha-reductase Inhibitors for prostate cancer prevention.
- Finasteride Inhibits Human Prostate Cancer Cell Invasion through MMP2 and MMP9 Downregulation
- Risk factors for prostate cancer: a case-control study investigating selected key exposures and their interactions with predisposition genes
- Redefining hormone resistance in prostate cancer
- Androgen Deprivation Therapy in Prostate Cancer: Focusing on Sexual Side Effects
- Recent discoveries and developments of androgen receptor based therapy for prostate cancer
- Trends in the Development of New Drugs for Treatment of Benign Prostatic Hyperplasia
- Androgenetic alopecia and risk of prostate cancer: A systematic review and meta-analysis
- Multiple readout assay for hormonal (androgenic and antiandrogenic) and cytotoxic activity of plant and fungal extracts based on differential prostate cancer cell line behavior
- Incidence of liver toxicity associated with the use of flutamide in prostate cancer patients
- Anti-proliferative effect of terpenes on human prostate cáncer cells: natural sources and their potential role as chemopreventive agents.
- Association Between 5α-Reductase Inhibitors and Prostate Cancer Mortality
- 5α-Reductase type 2 gene variant associations with prostate cancer risk, circulating hormone levels and androgenetic alopecia
- Effects of Short-Term Finasteride on Apoptotic Factors and Androgen Receptors in Prostate Cancer Cells
- Development of a Doxazosin and Finasteride Transdermal System for Combination Therapy of Benign Prostatic Hyperplasia
- Early-onset baldness and the risk of aggressive prostate cancer: findings from a case–control study
- Vitamin D, Lipid Metabolism and Prostate Cancer